Paper Review Records
All Paper Review Records
12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
189
days
RNA editing of pathogenic variants causing inherited retinal diseases using endogenous ADAR-current and future perspectives
Authors
Manar Salameh; Nina Schneider; Johanna Valensi; Asodu Sandeep Sarma; Erez Y. Levanon; Shay Ben-Aroya; Dror SharonShow moreShow less
Affiliations
Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, 91120, Israel; The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, IsraelShow moreShow less
62
days
Advancing precision medicine in pancreatic cancer using novel biomarkers and clinical targets
Authors
Divya Murthy; Attila A. Seyhan; Petra den Hollander; Shaolei Lu; Nick A. Kuburich; Claire Gould; Andrew A. Karam; Katie Sun; Patrick G. Schupp; Howard Safran; Razelle Kurzrock; Wafik El-Deiry; Sendurai A. ManiShow moreShow less
Affiliations
Legorreta Cancer Center, Warren Alpert Medical School, Brown University, Providence, RI, United States; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI, United States; Joint Program in Cancer Biology, Brown University Health and Brown University, Providence, RI, United States; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, RI, United States; Hematology/Oncology Division, Department of Medicine, Brown University Health and Brown University, Providence, RI, United States; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin and the LaBahn Pancreatic Cancer Program, Milwaukee, WI, United States; Department of Medicine, Warren Alpert Medical School, Brown University, Providence, RI, United StatesShow moreShow less
166
days
Glucagon-like peptide-1 receptor agonists across anti-inflammation
Authors
Daohong ChenShow moreShow less
Affiliations
Research Institute, Changshan Biochemical Pharmaceutical, 71 Menglong Street, Zhengding New District, Shijiazhuang, Hebei, 050800, ChinaShow moreShow less
248
days
Dual-targeting strategies for cancer and diabetes: Converging pharmacological pathways and repurposed therapies
Authors
Gurjit Kaur Bhatti; Ishtiaq Ahmed; Abhishek Sehrawat; Pushpender Kumar Sharma; Ramesh Kandimalla; Kawaljit Singh Kaura; Jasvinder Singh BhattiShow moreShow less
Affiliations
Department of Medical Lab Technology, University Institute of Allied Health Sciences, Chandigarh University, Mohali, 140413, Punjab, India; University Centre for Research and Development, Chandigarh University, Mohali, 140413, Punjab, India; Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, India; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, 303002, India; Amity Center of Nanobiotechnology and Nanomedicine, Amity University Rajasthan, Jaipur, India; Department of Biochemistry, Kakatiya Medical College, Warangal, India; Department of Urology, All India Institute of Medical Sciences, Bathinda, Punjab, IndiaShow moreShow less
186
days
Metabolic dysregulation: Its role in diabetes mellitus and cancers
Authors
Shuang Dai; Jiacheng Li; Jing Xia; Yingtong Liu; Yan LiShow moreShow less
Affiliations
Health and Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, China; College of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaShow moreShow less
31
days
Viral triggers and genetic predisposition in ocular autoimmunity: unraveling the breakdown of immune privilege and advancing targeted therapeutics
Authors
Jianhao Bai; Zhiyong Wu; Zhongqi Wan; Chun Zhao; Yin Liu; Tianyu WangShow moreShow less
Affiliations
Department of Ophthalmology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China; Shanghai Heping Eye Hospital, Shanghai, China; Department of Ophthalmology, Shanghai Tenth People's Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China; Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Ningbo Key Laboratory of Medical Research on Blinding Eye Diseases, Ningbo Eye Institute, Ningbo Eye Hospital, Wenzhou Medical University, Ningbo, 315040, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days